1.Anxiety and Agitation in BPSD.
Journal of Korean Geriatric Psychiatry 2000;4(1):24-33
Recently attention to the behavior and psychological symptoms of dementia (BPSD) is increasing repidly. Agitation is one of the BPSDs that contributes to the heavy burden on the caregiver and family. But, the definition of the agitation is controversial, and the rating scales for its measurements have limitations. We reviewed the literatures and our experiences to propose a rational strategy for controlling the agitating behaviors in the demented elderly. In the assessment of agitation in dementia, the top priority is a careful evaluation of the patient's medical, psychiatric, and environmental status. After pertinent medical conditions have been identified and managed, significant agitation may still be present and require intervention. Basically both behavior/environmental intervention and psychopharmacologic management are recommended in almost all situations. For patients with mild agitation, the clinician may consider implementing behavioral/environmental intervention singwarly. In severe agitation, however, pharmacologic approach is a preferred strategy, and can be administered according to the prevailing syndromes, such as psychosis, depression, delirium, anxiety, and so on. In practice high potency conventional antipsychotics and benzodiazepines are fregnently prescribed, but recently, drugs that have fewer long-term side effects, such as risperidone and divalproex are highly recommended. Due to the decreased pharmacokinetics and pharmacodynamics, drug dosages for the demented elderlies are much lower compared to younger patients. Side effects of the maintaining psychotropics should be monitored cautiously as well. Although some patients require long-term treatment, it is important to taper off and discontinue the medication periodically following a satisfactory improvement.
Aged
;
Antipsychotic Agents
;
Anxiety*
;
Benzodiazepines
;
Caregivers
;
Delirium
;
Dementia
;
Depression
;
Dihydroergotamine*
;
Drug Therapy
;
Humans
;
Pharmacokinetics
;
Psychotic Disorders
;
Risperidone
;
Valproic Acid
;
Weights and Measures
2.Dementia Mortality and Related Clinical Factors at a Nursing Home.
Youngjae HWANG ; Kyeonghyeong JHO ; Jinsook CHOI ; Youngmin SHIN
Journal of Korean Geriatric Psychiatry 2002;6(2):110-116
OBJECTIVE: This study was designed to evaluate the cause of mortality in patients with dementia, including Alzheimer's disease and multi-infarct dementia, and those without dementia. METHOD: Hospital records of geriatric patients (> or =65) in nursing home having dementia were reviewed retrospectively for 6 years. The total number of patients was 351 (the number of demented patients was 146 and those without dementia was 68). Of the ones with dementia, 146 had dementia of Alzheimer's type, 101 patients had vascular dementia, and 36 patients had non-specific dementia. This study focused on the different complications associated with Alzheimer's disease and cerebrovascular dementia. RESULT: 1) The average age at death of demented patient is higher than the non-demented population;however, there is no difference in age between Alzheimer's disease and vascular dementia. 2) There is no difference in time spent in the nursing home among the non-demented group, Alzheimer's disease and vascular dementia group from admission to death. The life expectancy of male patients with Alzheimer's disease after admission to the nursing home is significant shorter than their female counterpart. 3) Patients with vascular dementia have a higher incidence of hypertension, atherosclerotic disease, and diabetes than the Alzheimer's patients. 4) The main overall causes of the death (in nursing home patients) are infection and sepsis. In Alzheimer's disease's, sepsis is the major cause of death, while in vascular dementia, atherosclerotic disease is the number one cause. CONCLUSION: Knowledge of the causes of the death in demented patients may help the management of the possible complications associated with the different types of dementia. However, long-term research is then needed to analyze the survival rates of demented nursing home patients.
Alzheimer Disease
;
Cause of Death
;
Dementia*
;
Dementia, Multi-Infarct
;
Dementia, Vascular
;
Female
;
Hospital Records
;
Humans
;
Hypertension
;
Incidence
;
Life Expectancy
;
Male
;
Mortality*
;
Nursing Homes*
;
Nursing*
;
Retrospective Studies
;
Sepsis
;
Survival Rate
3.Influence of Recognition on Low Fertility and Views of Marriage on Childbirth Will in University Students
Jummi PARK ; Nayeon SHIN ; Youngmin KIM ; Seongyeong KANG ; Suyeon KIM ; Wooyoung AHN
Journal of the Korean Society of Maternal and Child Health 2019;23(4):261-268
PURPOSE:
The purpose of this study was to identify the influences of recognition on low fertility and views of marriage on childbirth will in university students.
METHODS:
Participants were 190 university students in Chungchungnamdo province, Korea. The data were collected from May to October 2018 and examined using descriptive statistics, t-test, analysis of variance, Pearson correlation and multiple regression with IBM SPSS Statistics ver. 24.0.
RESULTS:
Childbirth will was significantly correlated with recognition on low fertility (r=0.20, p=0.002) and views on marriage (r=0.53, p<0.001). Factors associated with childbirth will were views on marriage (β=0.24, p<0.001).
CONCLUSION
Theses results suggests that views on marriage have important influences on childbirth will in university students. To improve childbirth will, the positive views on marriage need to be formulated in university students.
4.Comparison of oxycodone and fentanyl for postoperative patient-controlled analgesia after laparoscopic gynecological surgery.
Joong Ho PARK ; Chiu LEE ; Youngmin SHIN ; Ji Hyun AN ; Jong Seouk BAN ; Ji Hyang LEE
Korean Journal of Anesthesiology 2015;68(2):153-158
BACKGROUND: Opioids are widely used in boluses and patient-controlled analgesia (PCA) for postoperative pain control. In this study, we compared the effects of oxycodone and fentanyl on postoperative pain in patients with intravenous patient-controlled analgesia (IV-PCA) after laparoscopic gynecological surgery. METHODS: Seventy-four patients undergoing elective total laparoscopic hysterectomy or laparoscopic myomectomy were randomly assigned to the administration of either fentanyl or oxycodone using IV-PCA (potency ratio 1 : 60). The cumulative dose administered in the patient-controlled mode during the initial 48 hours after the operation was measured. Patients were also assessed for postoperative pain severity, adverse effects, and patient satisfaction. RESULTS: No significant differences were observed in patient satisfaction with the analgesia during the postoperative period. Patients in the oxycodone group experienced significantly more dizziness compared to the fentanyl group. Patients in the oxycodone group showed significantly lower consumption of opioid in the patient-controlled mode (10.1 +/- 8.5 ml vs. 16.6 +/- 12.0 ml, P = 0.013). CONCLUSIONS: Our data suggest that oxycodone and fentanyl demonstrated similar effects, and therefore oxycodone may be a good alternative to fentanyl in postoperative pain management. Further studies in various clinical settings will be needed to determine the adequate potency ratio.
Analgesia
;
Analgesia, Patient-Controlled*
;
Analgesics, Opioid
;
Dizziness
;
Female
;
Fentanyl*
;
Gynecologic Surgical Procedures*
;
Humans
;
Hysterectomy
;
Oxycodone*
;
Pain, Postoperative
;
Patient Satisfaction
;
Postoperative Period
5.The Study of Characteristics of Cutaneous Manifestations of Kawasaki Disease in Korean Patients (2006-2010).
Jae Wan GO ; Lucy Youngmin EUN ; Shin Han KIM ; Sang Yoon LEE ; Jin Young JUNG ; Han Kyoung CHO
Korean Journal of Dermatology 2011;49(9):795-800
BACKGROUND: Kawasaki disease (KD) is an acute inflammation of middle-sized arteries such as the coronary artery. KD is an important disease due to its high mortality rate, which approaches 1-2% without appropriate treatment. Since the various mucocutaneous lesions of KD are related to the dermatologic field, dermatologists should take an interest in this disorder and understand the lesions. OBJECTIVE: To evaluate the characteristics of cutaneous lesions in Korean patients with KD. METHODS: A total of 919 patients with KD were assessed at the department of pediatric cardiology and dermatology, Myongji hospital between January 2006 and December 2010. RESULTS: Of the 919 patients, 566 (61.6%) were diagnosed with typical KD and 353 (38.4%) with atypical KD. KD was most frequent in the 4 year-old group (22.7%), and the ratio of male to female was 1.5:1. Among the mucocutaneous manifestations, erythema of the oropharyngeal mucosa (75.7%) occurred most frequently, followed by polymorphous trunk rash (41.7%), and changes of palms and soles (25.6%). A total of 606 patients (65.9%) with KD had associated diseases as follows: pneumonia (211 patients; 34.8%), pharyngotonsilitis (168 patients; 27.7%), gastroenteritis (132 patients; 21.8%), asthma (15 patients, 2.5%), atopic dermatitis (11 patients, 1.8%). CONCLUSION: Our study shows that change in the lips or oral cavity is the most common mucocutaneous manifestation in both classic and atypical KD. Also, morbiliform rash is the most common pattern of polymorphous rashes. Interestingly, erythema multiforme-like lesions occupied accounted for a considerable portion of KD cases compared to previous studies.
Arteries
;
Asthma
;
Cardiology
;
Coronary Vessels
;
Dermatitis, Atopic
;
Dermatology
;
Erythema
;
Exanthema
;
Female
;
Gastroenteritis
;
Humans
;
Inflammation
;
Lip
;
Male
;
Mouth
;
Mucocutaneous Lymph Node Syndrome
;
Mucous Membrane
;
Pneumonia
6.Effect of Intermittent Cyclic Etidronate Treatment on Bone Mineral Density of Postmenopausal Osteoporosis: Comparison with Continuous Estrogen Therapy.
Yunjong LEE ; Changdal YOO ; Kichul SHIN ; Seongwook KANG ; Eunbong LEE ; Hanjoo BAEK ; Hyuna KIM ; Soohee CHOI ; Kyungsil LIM ; Youngmin CHOI ; Yeongwook SONG
The Journal of the Korean Rheumatism Association 1999;6(1):44-52
No abstract available.
Arthritis, Rheumatoid
;
Bone Density*
;
Estrogens*
;
Etidronic Acid*
;
Female
;
Humans
;
NF-kappa B
;
Osteoporosis, Postmenopausal*
7.Minor Physical Anomalies in Patients with Schizophrenia.
Eun Jeong JOO ; Seong Hoon JEONG ; So Jin MAENG ; Se Chang YOON ; Jong Hoon KIM ; Chul Eung KIM ; Youngmin SHIN ; Yong Sik KIM
Journal of the Korean Society of Biological Psychiatry 2002;9(2):140-151
OBJECT AND METHOD: Minor physical anomalies(MPAs) are frequently seen in patients with schizophrenia. MPAs are considered to arise from the anomalous development of ectoderm-originated tissues in the developing fetus. Since the central nervous system originates from ectoderm, MPAs can be regarded as externally observable and objective indicators of the aberrant development which might have taken place in the central nervous system. To investigate whether MPAs are more frequent in schizophrenic patients, the frequencies of MPAs were compared between schizophrenic patients and normal controls. Total 245 schizophrenic patients diagnosed with DSM-IV(male : 158, female : 87), and 418 normal control subjects(male : 216, female : 202) were included in this study. The MPAs were measured using the modified Waldrop scale with fifteen items in six bodily regions; head, eye, ear, mouth, hand, and foot. RESULT: The total scores of Waldrop scale were 4.40+/-1.93(mean+/-standard deviation) in patients and 3.43+/- 1.68 in controls for females, and for males, 4.58+/-1.75 in patients and 4.28+/-1.59 in controls. For females, the excess of MPAs in schizophrenic patients was statistically significant(t-test : p<0.001). For males, schizophrenic patients also showed more MPAs than normal controls, but this tendency did not reach statistical significance (t-test : p=0.094). When the modified Waldrop total scores excluding head circumference were compared, the total scores in schizophrenic patients were significantly higher for both male and female subjects(t-test : male p<0.001, female p=0.001). The individual anomaly items included in Waldrop scale were also investigated. The items of epicanthus, hypertelorism, malformed ears, syndactylia were significantly more frequent in schizophrenic patients. In contrast, the items of adherent ear lobes, asymmetric ears, furrowed tongue, curved fifth finger, single palmar crease and big gap between toes did not show any differences in frequency between schizophrenic patients and normal controls. Since a lot of statistical analyses showed different results between male and female subjects, it seems to be necessary to consider gender as an important controlling variable for the analysis, however only the item of head circumference showed statistically significant gender-related difference according to log-linear analysis. CONCLUSION: With a relatively large sample size, the frequencies of MPAs enlisted in Waldrop scale were compared between schizophrenic patients and normal controls in this study. MPAs were more frequently seen in schizophrenic patients and, especially, several specific items in the Waldrop scale showed prominent excess in schizophrenic patients. Although definite conclusions cannot be drawn due to the inherent limitation of the study using Waldrop scale, these results seem to support the possibility that aberrant neurodevelopmental process might be involved in the pathogenesis of schizophrenia in some of the patients.
Central Nervous System
;
Ear
;
Ectoderm
;
Female
;
Fetus
;
Fingers
;
Foot
;
Hand
;
Head
;
Humans
;
Hypertelorism
;
Male
;
Mouth
;
Sample Size
;
Schizophrenia*
;
Syndactyly
;
Toes
;
Tongue, Fissured
8.Hepatocellular carcinoma and cancer-related mortality after kidney transplantation with rituximab treatment
Hayoung LEE ; Young Hoon KIM ; Seong Jun LIM ; Youngmin KO ; Sung SHIN ; Joo Hee JUNG ; Chung BAEK ; Hyosang KIM ; Su-Kil PARK ; Hyunwook KWON
Annals of Surgical Treatment and Research 2022;102(1):55-63
Purpose:
There are increased therapeutic usages of rituximab in kidney transplantation (KT). However, few studies have evaluated the effect of rituximab on cancer development following KT. This study aimed to evaluate the effect of rituximab on the cancer occurrence and mortality rate according to each type of cancer.
Methods:
Five thousand consecutive recipients who underwent KT at our center were divided into era1 (1990–2007) and era2-rit– (2008–2018), and era2-rit+ (2008–2018) groups. The era2-rit+ group included patients who received single-dose rituximab (200–500 mg) as a desensitization treatment 1–2 weeks before KT.
Results:
The 5-year incidence rates of malignant tumors after KT were 3.1%, 4.3%, and 3.5% in the era1, era2-rit–, and era2-rit+ group, respectively. The overall incidence rate of cancer after transplantation among the 3 study groups showed no significant difference (P = 0.340). The overall cancer-related mortality rate was 17.1% (53 of 310). Hepatocellular carcinoma (HCC) had the highest mortality rate (61.5%) and relative risk of cancer-related death (hazard ratio, 8.29; 95% confidence interval, 2.40–28.69; P = 0.001). However, we found no significant association between rituximab and the incidence of any malignancy.
Conclusion
Our results suggest that single-dose rituximab for desensitization may not increase the risk of malignant disease or cancer-related mortality in KT recipients. HCC was associated with the highest risk of cancer-related mortality in an endemic area of HBV infection.
9.Beneficial effects of posttransplant dipeptidyl peptidase-4 inhibitor administration after pancreas transplantation to improve β cell function
Hye-Won JANG ; Chang Hee JUNG ; Youngmin KO ; Seong Jun LIM ; Hye Eun KWON ; Joo Hee JUNG ; Hyunwook KWON ; Young Hoon KIM ; Sung SHIN
Annals of Surgical Treatment and Research 2021;101(3):187-196
Purpose:
Dipeptidyl peptidase-4 (DPP-4) inhibitors lower blood glucose levels and enhance the function of pancreatic βcells. Yet, it is unknown whether posttransplant administration of DPP4 inhibitors is beneficial for pancreas transplant recipients.
Methods:
We thus retrospectively analyzed the records of 312 patients who underwent pancreas transplantation between 2000 and 2018 at Asan Medical Center (Seoul, Korea) and compared the metabolic and survival outcomes according to DPP-4 inhibitor treatment.
Results:
The patients were divided into the no DPP-4 inhibitor group (n = 165; no treatment with DPP-4 inhibitors or treated for <1 month) and the DPP-4 inhibitor group (n = 147; treated with DPP-4 inhibitors for ≥1 month). There were no significant differences in levels of glucose, hemoglobin A1c, and insulin between the 2 groups during 36 months of follow-up. However, the level of C-peptide was significantly higher in the DPP-4 inhibitor group at 1, 6, and 24 months posttransplant (all P < 0.05). Moreover, the DPP-4 inhibitor group had significantly higher rates of overall (log-rank test, P = 0.009) and death-censored (log-rank test, P = 0.036) graft survival during a 15-year follow-up.
Conclusion
Posttransplant DPP-4 inhibitor administration may help improve the clinical outcomes including β cell function after pancreas transplantation.
10.Beneficial effects of posttransplant dipeptidyl peptidase-4 inhibitor administration after pancreas transplantation to improve β cell function
Hye-Won JANG ; Chang Hee JUNG ; Youngmin KO ; Seong Jun LIM ; Hye Eun KWON ; Joo Hee JUNG ; Hyunwook KWON ; Young Hoon KIM ; Sung SHIN
Annals of Surgical Treatment and Research 2021;101(3):187-196
Purpose:
Dipeptidyl peptidase-4 (DPP-4) inhibitors lower blood glucose levels and enhance the function of pancreatic βcells. Yet, it is unknown whether posttransplant administration of DPP4 inhibitors is beneficial for pancreas transplant recipients.
Methods:
We thus retrospectively analyzed the records of 312 patients who underwent pancreas transplantation between 2000 and 2018 at Asan Medical Center (Seoul, Korea) and compared the metabolic and survival outcomes according to DPP-4 inhibitor treatment.
Results:
The patients were divided into the no DPP-4 inhibitor group (n = 165; no treatment with DPP-4 inhibitors or treated for <1 month) and the DPP-4 inhibitor group (n = 147; treated with DPP-4 inhibitors for ≥1 month). There were no significant differences in levels of glucose, hemoglobin A1c, and insulin between the 2 groups during 36 months of follow-up. However, the level of C-peptide was significantly higher in the DPP-4 inhibitor group at 1, 6, and 24 months posttransplant (all P < 0.05). Moreover, the DPP-4 inhibitor group had significantly higher rates of overall (log-rank test, P = 0.009) and death-censored (log-rank test, P = 0.036) graft survival during a 15-year follow-up.
Conclusion
Posttransplant DPP-4 inhibitor administration may help improve the clinical outcomes including β cell function after pancreas transplantation.